Suchen
MeiraGTx Holdings PLC
MGTXZur Watchlist hinzufügen
11.135USD
-0.615-5.23%
Trading geöffnet 09/24, 15:24（ET）
1.03BMarktkapitalisierung
VerlustKGV TTM
Über MeiraGTx Holdings PLC Unternehmen
MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company. It has a pipeline of late-stage clinical programs, including Parkinson’s disease, radiation-induced xerostomia and AIPL1-associated retinal dystrophy. It is focused on vivo delivery of vectorized biologic therapeutics addressing unmet needs in prevalent disorders, including severe forms of xerostomia, neurodegenerative diseases and ocular diseases, including inherited retinal diseases (IRDs), and large degenerative ocular diseases. The Company’s product pipeline includes Botaretigene Sparoparvovec for the treatment of X-linked Retinitis Pigmentosa; AAV-hAQP1 for the treatment of Radiation-Induced Grade 2/3 Xerostomia; AAV-hAQP1 for the treatment of Sjogren’s Syndrome; AAV-GAD for the treatment of Parkinson’s Disease; AAV-RPE65 for the treatment of RPE65-Associated Retinal Dystrophy; AAV-CNGB3 and AAV-CNGA3 for the treatment of Achromatopsia; AAV-AIPL1 for the treatment of LCA4, and others.
MeiraGTx Holdings PLC Profil
BörsenkürzelMGTX
Name des UnternehmensMeiraGTx Holdings PLC
IPO-datumJun 08, 2018
CEOForbes (Alexandria)
Anzahl der mitarbeiter381
WertpapierartOrdinary Share
GeschäftsjahresendeJun 08
Addresse655 Third Avenue
StadtNEW YORK
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl10017
Telefon16468607985
Websitehttps://meiragtx.com/
BörsenkürzelMGTX
IPO-datumJun 08, 2018
CEOForbes (Alexandria)
Führungskräfte von MeiraGTx Holdings PLC
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Alexandria Forbes, Ph.D.
Dr. Alexandria Forbes, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.33M
-4.68%
Dr. Alexandria Forbes, Ph.D.
Dr. Alexandria Forbes, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.33M
-4.68%
Dr. Alexandria Forbes, Ph.D.
Dr. Alexandria Forbes, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.33M
-4.68%
Mr. Richard Giroux
Mr. Richard Giroux
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
998.68K
-5.61%
Mr. Richard Giroux
Mr. Richard Giroux
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
998.68K
-5.61%
Mr. Richard Giroux
Mr. Richard Giroux
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
998.68K
-5.61%
Dr. Stuart Naylor, Ph.D.
Dr. Stuart Naylor, Ph.D.
Chief Development Officer
Chief Development Officer
640.85K
-4.32%
Dr. Stuart Naylor, Ph.D.
Dr. Stuart Naylor, Ph.D.
Chief Development Officer
Chief Development Officer
640.85K
-4.32%
Dr. Stuart Naylor, Ph.D.
Dr. Stuart Naylor, Ph.D.
Chief Development Officer
Chief Development Officer
640.85K
-4.32%
Dr. Keith R. Harris, Ph.D.
Dr. Keith R. Harris, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
200.00K
+37.50%
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Alexandria Forbes, Ph.D.
Dr. Alexandria Forbes, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.33M
-4.68%
Dr. Alexandria Forbes, Ph.D.
Dr. Alexandria Forbes, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.33M
-4.68%
Dr. Alexandria Forbes, Ph.D.
Dr. Alexandria Forbes, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.33M
-4.68%
Mr. Richard Giroux
Mr. Richard Giroux
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
998.68K
-5.61%
Mr. Richard Giroux
Mr. Richard Giroux
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
998.68K
-5.61%
Mr. Richard Giroux
Mr. Richard Giroux
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
998.68K
-5.61%
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von MeiraGTx Holdings PLC?
Die fünf größten Anteilseigner von MeiraGTx Holdings PLC sind: Dr. Alexandria Forbes, Ph.D.
Wie viele Institutionen halten Anteile an MeiraGTx Holdings PLC (MGTX)?
Mit Stand vom 2026Q1 halten 249 Institutionen Anteile an MeiraGTx Holdings PLC, mit einem Gesamtmarktwert von etwa 53.71M, was 59.59% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -1739317.00 gestiegen.